Birth control pill has lasting protective effects against endometrial cancer
the ONA take:
A new study from researchers at the University of Oxford in the United Kingdom reports that oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
Previous studies linked the use of the birth control pill with reduced incidence of endometrial cancer, but whether this continued after the use is discontinued was unknown.
In this study, the researchers used a dataset that included 27,276 women with endometrial cancer and 115,743 women without the disease from 36 epidemiological studies.
They calculated that the risk of endometrial cancer was reduced by approximately 25% for every 5 years of use. Furthermore, the reduced risk persisted for more than 30 years after birth control pills were discontinued.
The decrease in the amount of estrogen birth control pills also did not diminish the protective effects of oral contraceptive use.
An estimated 400,000 cases of endometrial cancer were prevented in developed countries due to the use of birth control pills between 1965 and 2014, with approximately 200,000 cases prevented after 2005.
Oral contraceptives protect against endometrial cancer, and the protective benefit lasts for many years after women stop taking the pills.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|